Systematic review with meta‐analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis
Alimentary Pharmacology & Therapeutics2014Vol. 39(6), pp. 557–568
Citations Over TimeTop 10% of 2014 papers
Abstract
Carvedilol reduces portal hypertension significantly more than propranolol. However, available data do not allow a satisfactory comparison of adverse events. These results suggest a potential for a cautious clinical use.
Related Papers
- → Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study(2018)52 cited
- → Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests?(2021)13 cited
- Are there any alternative methods to hepatic venous pressure gradient in portal hypertension assessment?(2013)
- → Evaluation of Carvedilol for the Treatment of Portal Hypertension(2004)26 cited
- → Brief Review of Portal Hypertension Related Complications(2021)